EXHIBIT 10.46
STOCK PURCHASE AGREEMENT
This agreement is dated December 10, 2001 between ____________
("Purchaser"), and NeoTherapeutics, Inc. ("Company"), whereby the parties agree
as follows:
The Purchaser shall buy and the Company agrees to sell _______ shares
("Shares") of the Company's Common Stock at a price of $3.85 per share for a
total amount of $___________. The Shares have been registered on a Form S-3,
File No. 333-53108, which registration statement has been declared effective by
the Securities and Exchange Commission. The Shares are free of restrictive
legends and are free of any resale restrictions. The Company is delivering
herewith a prospectus supplement on Form 424 (b)(2) regarding the sale of the
Shares prior to funding.
The Purchaser shall wire the purchase amount to the Company to the
account set forth below.
Company Wire Transfer Instructions:
Chase Manhattan Bank
0 Xxxxx Xxxxx
Xxx Xxxx, XX 00000
ABA # 021 000 021
FBO Xxxxxxx Xxxxx Xxxxxx
A/C # 066-198038
For Further Credit to:
Neotherapeutics, Inc.
A/C # 561-04051-19-103
The Company shall cause its transfer agent to transmit the Shares
electronically to the Purchaser by crediting the account set forth below through
the Deposit Withdrawal Agent Commission system.
Purchaser DWAC Instructions:
--------------
DTC #____
--------------
2
AGREED AND ACCEPTED:
NeoTherapeutics, Inc.
By:
-----------------------------------------
Name:
Title:
PURCHASER:
[Purchaser Name]
By:
-----------------------------------------
Name:
Title:
